Energy News / Whistleblower Institute

$19.8 Million Settlement Reached over Allegations of Drug Overcharges to the Department of Veterans Affairs Against Sanofi Pasteur Announced by Whistleblower Institute

Via: ReleaseWire

Updated 9:15 AM CDT, Tue, August 29,2017

The Whistleblower Institute announces that Sanofi Pasteur reached a $19.8 million settlement.

San Diego, CA -- (SBWIRE) -- 08/29/2017 -- The Whistleblower Institute announces that Sanofi Pasteur reached a $19.8 million settlement over allegations of drug overcharges to the Department of Veterans Affairs.

Those who have a similar case or experienced a similar situation or any other wrongdoing within a corporation have certain options and should contact the Whistleblower Institute at mail@whistleblowerinstitute.com or call: 619-452–1218. There are no costs or obligations to you.

According to the Department of Justice, allegations arose from a lawsuit that claimed Sanofi Pasteur incorrectly calculated drug prices and thereby overcharged the U.S. Department of Veterans Affairs (VA) for drugs under two contracts between 2002 and 2011.

The Veterans Health Care Act mandates that pharma companies charge the so-called federal ceiling price (FCP) for their drugs. The FCPs for certain drugs are exactly what Sanofi Pasteur miscalculated in this case.

"It is important that pharmaceutical companies provide complete, accurate, and current information to the VA about the pricing of their drugs," said Acting Assistant Attorney General Chad A. Readler of the Justice Department's Civil Division. "The Department of Justice will ensure that pharmaceutical companies follow the rules for drug pricing when selling to the government."

Sanofi Pasteur allegedly has paid millions to resolve False Claims Act allegations. In 2012, the company paid over $109 million in a False Claims Act investigation regarding its knee injection, Hyalgan. Allegedly, the company used free samples as kickbacks to lower the drug's effective price, to avoid cutting its actual invoiced price and trigger lower reimbursements.

Reportedly, in addition to paying approximately $19.8 million, Sanofi Pasteur has agreed that it will not pursue claims for reimbursement for sales where it contends its error in calculating the FCP resulted in a lower price to the VA.

Based in Lyon, France, Sanofi Pasteur is the vaccines division of the multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines.

The Whistleblower Institute is an information portal for current or former employees and other people having insight information about wrongdoing and other illegal activities by individuals either individually or within corporations, through company culture and or within international affairs. Whistleblowers should keep in mind that under the Dodd-Frank Act any person who provides the Securities and Exchange Commission ("SEC") with original information that leads to a successful enforcement action with over $1 million recovered must be awarded between 10%-30% of the total amount recovered. In order to determine the total amount of the reward there are numerous factors that need to be considered. Whistleblower actions are complex and our goal is to guide any whistleblower every step of the way. The Whistleblower Institute is dedicated to partnering with any individual who have information about fraud and we work with many of the best law firms worldwide.

Those who have a similar case or experienced a similar situation or any other wrongdoing within a corporation have certain options and should contact the Whistleblower Institute.

Contact:
Whistleblower Institute
2534 State Street - Suite 406
San Diego, CA 92101, USA
Phone: +1 (619) 452–1218
Facsimile: +1 (619) 785 – 3185
Email: mail@whistleblowerinstitute.com

The material was prepared by the Whistleblower Institute for informational purposes only and is not legal or financial advice. The information is provided only as general information which may or may not reflect the most currently available public information, is not provided as a basis for any established or existing relationship, and is not intended to constitute legal or financial advice, or to substitute for obtaining such advice from an attorney or other advisor licensed in your state.

For more information on this press release visit:
http://www.sbwire.com/press-releases/198-million-settlement-reached-over-allegations-of-drug-overcharges-to-the-department-of-veterans-affairs-against-sanofi-pasteur-announced-by-whistleblower-institute-854893.htm

Media Relations Contact
Whistleblower Institute
619-452–1218
Email: Click to Email Whistleblower Institute
Web: http://www.whistleblowerinstitute.com